Stéphane Culine

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma

Joaquim Bellmunt, Ronald de Wit, David J. Vaughn et al. · New England Journal of Medicine · 2017 · 3.4K citations · Full text

Medicine, Oncology, Pharmacology +17

Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up

Yves Fradet, Joaquim Bellmunt, David J. Vaughn et al. · Annals of Oncology · 2019 · 488 citations · Full text

Medicine, Oncology, Pharmacology +14

Multicentre, phase II study evaluating capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer

P. Fumoleau, R. Largillier, Christine Clippe et al. · European Journal of Cancer · 2003 · 307 citations

Medicine, Oncology, Pharmacology +16

The growing teratoma syndrome: results of therapy and long-term follow-up of 33 patients

Fabrice André, Karim Fizazi, Stéphane Culine et al. · European Journal of Cancer · 2000 · 243 citations

Medicine, Oncology, Pathology +7

Development and Validation of a Prognostic Model to Predict the Length of Survival in Patients With Carcinomas of an Unknown Primary Site

Stéphane Culine, Andrew Kramar, Mahasti Saghatchian et al. · Journal of Clinical Oncology · 2002 · 206 citations

Medicine, Biostatistics, Oncology +17